For years, women have relied on pills, injections, condoms, and IUDs for birth control. But side effects and discomfort have made many seek a safer, easier alternative ...
A planned U.S.-funded study of a hepatitis B vaccine drew widespread condemnation from researchers. Now the host country says ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been available for over 20 years but remain underutilized. Interest in these options ...
ZME Science on MSN
This FDA approved birth control method is effective but your doctor probably never mentioned it
For years, preventing pregnancy in the US has meant choosing between the lesser of several annoyances: remembering a daily pill, enduring the insertion of an IUD, or managing condom use. But another ...
DMPA is available in two injectable forms: an intramuscular injection, marketed under the name Depo Provera, that can only be administered by a provider, and one that is injected just under the skin.
In this retrospective cohort study, investigators assessed whether having stress-related psychiatric conditions influenced how the use of combined hormonal birth control affects the risk for major ...
Camille Seigle is a consultant who helps individuals and organizations unlock their potential. She co-authored a book with Ali Mann Stevens, inspired by their postpartum experiences. This essay is an ...
The U.S. Food and Drug Administration (FDA) has approved a major safety update to the label of Depo-Provera, a widely used birth control injection. Nearly 2,000 women have filed lawsuits against ...
The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...
CLEVELAND — The Food and Drug Administration has approved a new warning label for Depo-Provera, one of the most widely used birth control shots in the United States, alerting users to a potential risk ...
U.S. government regulators have approved a new brain tumor warning for Depo-Provera Lawsuits from more than 1,000 women claim they weren’t warned sooner Regulators in Europe and Canada previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results